CSIMarket


Gala Pharmaceutical Inc.  (GLAG)
Other Ticker:  
 


 

Gala Pharmaceutical Inc.

GLAG's Financial Statements and Analysis



Gala Pharmaceutical Inc. increased second quarter of 2019 net loss per share of $-0.02 compare to net loss per share of $-0.01 recorded in the same quarter a year ago a decrease compare to $-0.01 realized in previous quarter.


second quarter of 2019
Earnings Per Share Revenues
$ -0.02 $  0 Mill
$-0.01     Unch.    



Gala Pharmaceutical's Revenue fell by 0 % in second quarter of 2019 (May 31 2019) year on year, to $0 million and declined by sequentially.


Gala Pharmaceutical is

More on GLAG's Income Statement



Gala Pharmaceutical's in thesecond quarter of 2019 recorded net loss of $-2.131 million, an increase from net loss of $-0.398 million in II. Quarter a year ago.

Sequentially net loss advanced

More on GLAG's Growth

Gala Pharmaceutical Inventories
In May 31 2019 company's net cash and cash equivalents decreased by $0 million

More on GLAG's Cash flow Statement


Gala Pharmaceutical Inc. does not pay out common stock dividend.

In trailing twelve-month period Gala Pharmaceutical Inc. payed $ -0.01 cash per share, on a free-cash flow basis .


Tangible Book value fell to $ -0.03 per share from $ -0.01.

Company issued 9.51 million shares or 10.10 % in May 31 2019.


More on GLAG's Dividends

 Market Capitalization (Millions) 27
 Shares Outstanding (Millions) 104
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -




Gala Pharmaceutical Inc. does not pay out common stock dividend.

In trailing twelve-month period Gala Pharmaceutical Inc. had negative $ -0.01 cash flow per share, on a free-cash flow basis .


Tangible Book value fell to $ -0.03 per share from $ -0.01.

Company issued 9.51 million shares or 10.10 % in May 31 2019.


More on GLAG's Balance Sheets

 Market Capitalization (Millions) 27
 Shares Outstanding (Millions) 104
 Total Debt (Millions $) 0
 Revenue (TTM) (Millions $) -
 Net Income (TTM) (Millions $) -4
 Cash Flow (TTM) (Millions $) 0
 Capital Exp. (TTM) (Millions $) 0
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ -
   



Date modified: -0001-11-30T00:00:00+00:00





Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com